CDC Awards $148 Million Contract for Emergency Diagnostic Test Development
The five-year agreement with MRIGlobal aims to enhance laboratory readiness and response for public health emergencies.
Read More
Search Results for: point-of-care
New Blood Test Detects Active and Infectious Tuberculosis
The test identifies antibodies associated with active disease, potentially offering a faster alternative to sputum samples and existing screening methods.
Read More
Co-Diagnostics Joint Venture to Build Molecular Diagnostics Facility in Saudi Arabia
Co-Diagnostics and Arabian Eagle Manufacturing have secured land in Sudair Industrial City, Saudi Arabia, to build a facility for manufacturing molecular diagnostic instruments and assays, supporting regional expansion in the Middle East and North Africa.
Read More
Rapid Molecular Test for Flu and COVID-19 on FINDER Platform Gets FDA Clearance and CLIA-Waiver
The rapid RT-PCR assay runs on the FINDER platform, establishing it as a molecular point-of-care platform with multifunctional capabilities.
Read More
Rapid Urine Test Identifies Effective UTI Antibiotics in Under Six Hours
A rapid urine test identified effective UTI antibiotics in an average of 5.85 hours, matching standard lab accuracy in a University of Reading study published in the Journal of Antimicrobial Chemotherapy.
Read More